BR112018068544A2 - tc24-c4, antígeno para vacina contra doença de chagas com estabilidade melhorada e agregação diminuída - Google Patents
tc24-c4, antígeno para vacina contra doença de chagas com estabilidade melhorada e agregação diminuídaInfo
- Publication number
- BR112018068544A2 BR112018068544A2 BR112018068544A BR112018068544A BR112018068544A2 BR 112018068544 A2 BR112018068544 A2 BR 112018068544A2 BR 112018068544 A BR112018068544 A BR 112018068544A BR 112018068544 A BR112018068544 A BR 112018068544A BR 112018068544 A2 BR112018068544 A2 BR 112018068544A2
- Authority
- BR
- Brazil
- Prior art keywords
- improved stability
- chagas disease
- disease antigen
- decreased aggregation
- compositions
- Prior art date
Links
- 241000223109 Trypanosoma cruzi Species 0.000 title abstract 3
- 206010001935 American trypanosomiasis Diseases 0.000 title abstract 2
- 238000004220 aggregation Methods 0.000 title abstract 2
- 230000002776 aggregation Effects 0.000 title abstract 2
- 208000024699 Chagas disease Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000003247 decreasing effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662308054P | 2016-03-14 | 2016-03-14 | |
| PCT/US2017/022317 WO2017160849A1 (fr) | 2016-03-14 | 2017-03-14 | Antigène de vaccin de la maladie de chagas tc24-c4 à stabilité améliorée et agrégation réduite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018068544A2 true BR112018068544A2 (pt) | 2019-04-24 |
Family
ID=59851379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018068544A BR112018068544A2 (pt) | 2016-03-14 | 2017-03-14 | tc24-c4, antígeno para vacina contra doença de chagas com estabilidade melhorada e agregação diminuída |
Country Status (3)
| Country | Link |
|---|---|
| BR (1) | BR112018068544A2 (fr) |
| MX (1) | MX2018011226A (fr) |
| WO (1) | WO2017160849A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021076570A2 (fr) * | 2019-10-17 | 2021-04-22 | Baylor College Of Medicine | Antigènes de vaccin de la maladie de chagas à stabilité améliorée et agrégation réduite |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0976763B1 (fr) * | 1998-07-30 | 2003-11-05 | Innogenetics N.V. | Antigènes und immunoessais pour la maladie de Chagas |
| US7749717B2 (en) * | 2006-10-19 | 2010-07-06 | Abbott Laboratories | Methods for the detection and diagnosis of Trypanosoma cruzi infection |
| CA3023887A1 (fr) * | 2007-12-27 | 2009-07-09 | Abbott Laboratories | Anticorps anti t. cruzi et procedes d'utilisation |
| TWI690322B (zh) * | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
-
2017
- 2017-03-14 MX MX2018011226A patent/MX2018011226A/es unknown
- 2017-03-14 WO PCT/US2017/022317 patent/WO2017160849A1/fr active Application Filing
- 2017-03-14 BR BR112018068544A patent/BR112018068544A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017160849A1 (fr) | 2017-09-21 |
| MX2018011226A (es) | 2019-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017016636A2 (pt) | formulação líquida estável para anticorpos monoclonais | |
| CL2017001488A1 (es) | Benzamidas sustituidas con 1,3–tiazol–2–ilo | |
| CY1123953T1 (el) | Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης | |
| CL2015002334A1 (es) | Modificador del sabor dulce | |
| BR112016024319A2 (pt) | métodos para aumentar os níveis de hemácias e tratar anemia falciforme | |
| BR112017019300A2 (pt) | conjugado de fórmula genérica ama - l - x - s - ab, método para sintetizar um conjugado de fórmula genérica ama - l - x - s - ab, kit, método para sintetizar o composto ama - l - x', composição farmacêutica e método para tratar uma doença associada a células que apresentam um alvo | |
| BR112017005693A2 (pt) | método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica. | |
| BR112015022191A8 (pt) | compostos heteroarila e usos dos mesmos | |
| BR112015030514A2 (pt) | Composições e métodos para conjugação de anticorpos ativáveis | |
| BR112018077457A2 (pt) | composição farmacêutica para evitar ou tratar hiperinsulinismo congênito e seu método, hipoglicemia e seu método, síndrome metabólica e seu método e peptídeo isolado | |
| AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
| CL2017002082A1 (es) | Nuevas proteínas especificas para pioverdina y pioquelina | |
| BR112016002233A2 (pt) | composições de adoçante | |
| BR112016027871A2 (pt) | composição para melhorar a memória, a função de aprendizado e/ou função cognitiva | |
| EA202191513A1 (ru) | Снижение вязкости фармацевтических составов | |
| EA202090683A3 (ru) | Способы и композиции для лечения рака | |
| BR112017002761A2 (pt) | composições anti-metanogênicas e usos das mesmas | |
| BR112015017251A2 (pt) | composições farmacêuticas compreendendo doadores de nitroxil | |
| BR112015030356A2 (pt) | métodos de tratamento de uma taupatia | |
| BR112015004515A2 (pt) | composição imunogênica | |
| BR112015031417A2 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
| BR112016007487A2 (pt) | composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica | |
| BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
| BR112015023348A2 (pt) | método de inibição ou reversão da progressão da formação de catarata, composição oftálmica, e, método de tratamento de uma doença relacionada ao dobramento de proteínas | |
| BR112017026272A2 (pt) | ?composto, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor m1 muscarínico e uso do composto? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |